Equibles does not estimate personal net worth.
Get an email with a short summary when Agios Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AGIO alertsDr. Amar Zaidi has spoken on 2 investor events across 1 company, most recently for Agios Pharmaceuticals, Inc. on June 13, 2026. Agios Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Agios Pharmaceuticals, Inc. includes Brian Goff (CEO and Board Member), Jacqualyn Fouse (CEO and Board Member), David P. Schenkein (Chairman) and 7 others.
“I want to dive right in and talk a little bit about the state of sickle cell disease as it exists today. You've both collectively spent decades caring for patients with this illness.”
“I want to dive right in and talk a little bit about the state of sickle cell disease as it exists today. You've both collectively spent decades caring for patients with this illness.”
Transcript header (unverified)
Biotechnology · Healthcare
